Bioamber (BIOA) Tops Q4 EPS by 19c

Bioamber (NYSE: BIOA) reported Q4 EPS of ($0.20), $0.19 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $308 thousand versus the consensus estimate of $400 thousand.

For earnings history and earnings-related data on Bioamber (BIOA) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• FDA clears PM’s Zyn to market as lower cancer risk than cigarettes in 20 variants
• Circle Internet Group (CRCL) PT Lowered to $100 at US Tiger Securities